[7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia. NICE technological appraisal TA385.NICE, 2016. 教程,30多篇R教程,以及更多科研教程!
[7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia. NICE technological appraisal TA385.NICE, 2016.
[7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia. NICE technological appraisal TA385.NICE, 2016.
[7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia. NICE technological appraisal TA385.NICE, 2016. 点击链接:https://www.mediecogroup.com/zhuanlan/courses/,学习70多篇SPSS教程,30多篇R教程,以及更多科研教程!
The appraisal assessed evolocumab as monotherapy or in combination with a statin with or without ezetimibe, or in combination with ezetimibe (without statin therapy), in adult patients with primary hypercholesterolaemia (which includes mixed dyslipidaemia), for whom statins do not provide optimal ...
Charles Z, Pugh E, Barnett D. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance. Heart 2008 ;94:642-3Charles Z, Pugh E and Barnett D. Ezetimibe for the treatment of primary (heterozygous-familial and non-...
Heterozygous familial hypercholesterolaemia (HeFH) affects 1 in 500 people. This represents some 110000 of the UK population, similar to the number having type 1 diabetes. The great majority are either undetected or have received incorrect advice from a physician with inadequate knowledge of their ...
NICE guidance for identification and treatment of familial hypercholesterolaemia: Commentary 1.Tahseen A ChowdhuryCentre for Diabetes and Metabolic MedicineBarts and the London School of Medicine and DentistryHeart
NICE guidance for identification and treatment of familial hypercholesterolaemia: Commentary 2.EBSCO_AspHeart
Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance. BJOG 2009;116:478-9.Thorogood M, Seed M, De Mott K, Guideline Development Group. Management of fertility in women with familial hypercholesterolaemia: summary of NICE guid- ance. Br J Obstet ...